Ligand profile
1OG
Ligand co-crystallized with this exact protein (Protein Data Bank).
Bound to: VK055_0891 — beta-lactamase SHV-24
Identifiers
Database identifiers and provenance.
- Ligand ID
1OG- PDB
4jpm- UniProt (this protein)
P0AD64- Target protein
- VK055_0891
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 153.5
- −1 ≤ LogP ≤ 5 -0.09
- MW ≤ 500 Da 403.4
- LogP ≤ 5 -0.09
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 9
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 153.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC(=O)OC/C/1=C(/N=C\[C@H]([C@@H](S(=O)(=O)C1)C(=O)OC(C)(C)C)C=O)\C(=O)OCC(=O)OC/C/1=C(/N=C\[C@H]([C@@H](S(=O)(=O)C1)C(=O)OC(C)(C)C)C=O)\C(=O)O
InChI=1S/C16H21NO9S/c1-9(19)25-7-11-8-27(23,24)13(15(22)26-16(2,3)4)10(6-18)5-17-12(11)14(20)21/h5-6,10,13H,7-8H2,1-4H3,(H,20,21)/b12-11-,17-5-/t10-,13+/m0/s1InChI=1S/C16H21NO9S/c1-9(19)25-7-11-8-27(23,24)13(15(22)26-16(2,3)4)10(6-18)5-17-12(11)14(20)21/h5-6,10,13H,7-8H2,1-4H3,(H,20,21)/b12-11-,17-5-/t10-,13+/m0/s1
YIHDWMIOGFYWHU-GNOJNHLBSA-NYIHDWMIOGFYWHU-GNOJNHLBSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF00144' 'PF13354
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 1OG →
- PDB RCSB structure 4jpm →
- UniProt UniProt P0AD64 (same protein) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “1OG”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0891.
PDB 43
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).